Latest Technology News

Axel REE Limited has announced a maiden inferred gallium mineral resource of 100 million tonnes at its Caladão Project in Brazil, marking a significant milestone in critical minerals exploration amid global supply constraints.

WAM Income Maximiser Limited has reported a profitable first half since its April 2025 IPO, declaring its inaugural fully franked monthly dividend and setting guidance for dividend growth. The company’s diversified portfolio of ASX300 equities and investment grade corporate debt has delivered promising returns, underpinning its income and capital growth objectives.

The ASX has suspended the securities of 36 companies for failing to pay their annual listing fees by the August 21 deadline, with a looming delisting threat if fees remain unpaid by August 28.

INOVIQ Limited reported a $6.9 million net loss for FY25 while making significant strides in its exosome-based cancer diagnostics and therapeutics pipeline, including a breakthrough ovarian cancer screening test and promising CAR-exosome therapy results.

Great Northern Minerals Ltd has agreed to acquire the Catalyst Ridge Project in California’s Mountain Pass District, a key US rare earth and antimony region, supported by a $2.6 million capital raise to accelerate exploration.

Peninsula Energy outlines a revised production roadmap for its Lance uranium project in Wyoming, addressing commissioning delays and legacy contract burdens while securing fresh capital to fuel growth amid strong US nuclear energy momentum.

Carbonxt Group Limited has launched a fully underwritten $0.7 million Loyalty Options entitlement offer to existing shareholders, aiming to support working capital and operational growth following its new Kentucky facility commissioning.

NOVONIX Limited reports progress scaling its Chattanooga synthetic graphite plant, secures major funding, and benefits from U.S. tariffs on Chinese imports, while narrowing its half-year loss.

Monash IVF Group reported a 5.6% rise in underlying EBITDA for FY25, navigating a declining Australian IVF market and operational challenges. The company sets a cautious FY26 NPAT guidance of $20-23 million while focusing on regaining market leadership and implementing safety reforms.

Monash IVF Group reported steady FY25 financial results with revenue and EBITDA growth, while managing clinical incidents and a CEO transition. The company outlines cautious FY26 guidance amid industry headwinds.

Monash IVF Group reported a 6.7% revenue increase to $271.9 million in FY25 but saw an 8.1% decline in underlying net profit after tax to $27.4 million, impacted by market softness and operational incidents. The company outlines cautious FY26 guidance amid ongoing sector headwinds.

Rural Funds Group reported FY25 results aligned with forecasts, showcasing steady distributions and a diversified agricultural portfolio. The group maintains solid gearing and advances key development projects while forecasting stable AFFO and distributions for FY26.